Search

Your search keyword '"Gandjbakhch, Estelle"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Gandjbakhch, Estelle" Remove constraint Author: "Gandjbakhch, Estelle" Search Limiters Full Text Remove constraint Search Limiters: Full Text
404 results on '"Gandjbakhch, Estelle"'

Search Results

1. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

2. PFMG2025–integrating genomic medicine into the national healthcare system in France

3. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database.

4. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

6. Position paper on sustainability in cardiac pacing and electrophysiology from the Working Group of Cardiac Pacing and Electrophysiology of the French Society of Cardiology

7. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis

9. Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.

10. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators

14. Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease

15. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices

16. Clinical differences between drug‐induced type 1 Brugada pattern and syndrome

17. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy

18. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

19. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy:European Task Force consensus report

20. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers

21. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy : European Task Force consensus report

22. Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

26. NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis

27. Prevalence and Significance of Rare Genetic Variants in AKAP9 in Inherited Cardiac Diseases

34. Pre‐emptive treatment of heart failure exacerbations in patients managed with the HeartLogic™ algorithm.

35. Effectiveness of Deep Sedation for Patients With Intractable Electrical Storm Refractory to Antiarrhythmic Drugs

36. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices

38. A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study

39. Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

40. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia.

41. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia

42. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study

43. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study

44. Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study

45. Feasibility of a New Regional Myocardial Strain Parameter for the Detection of Wall Motion Abnormalities in Arrhythmogenic Right Ventricular Cardiomyopathy

46. Abnormal Cellular Phenotypes Induced by Three TMPO/LAP2 Variants Identified in Men with Cardiomyopathies

47. Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia

49. Hypogonadism as a Reversible Cause of Torsades de Pointes in Men

Catalog

Books, media, physical & digital resources